Tae‐Wook Chun

Active 1995–2025

Also published as
Tae-Wook Chun · Tae Wook Chun
96
Papers
23,057
Citations
75
h-index
95
i10-index

Citations

Citations per year for Tae‐Wook Chun1993: 2 citations1994: 5 citations1997: 15 citations1998: 62 citations1999: 99 citations2000: 107 citations2001: 130 citations2002: 160 citations2003: 172 citations2004: 113 citations2005: 107 citations2006: 103 citations2007: 124 citations2008: 139 citations2009: 201 citations2010: 175 citations2011: 242 citations2012: 206 citations2013: 238 citations2014: 239 citations2015: 231 citations2016: 218 citations2017: 190 citations2018: 197 citations2019: 704 citations2020: 728 citations2021: 643 citations2022: 498 citations2023: 419 citations2024: 722 citations2025: 316 citations2026: 3 citations1995–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,641 citing papers, 40% of this breakdownUnited Kingdom: 346 citing papers, 5.2% of this breakdownCanada: 338 citing papers, 5.1% of this breakdownChina: 291 citing papers, 4.4% of this breakdownFrance: 290 citing papers, 4.4% of this breakdownGermany: 257 citing papers, 3.9% of this breakdownAustralia: 218 citing papers, 3.3% of this breakdownItaly: 203 citing papers, 3.1% of this breakdownNetherlands: 185 citing papers, 2.8% of this breakdownSpain: 176 citing papers, 2.7% of this breakdownSwitzerland: 162 citing papers, 2.5% of this breakdownSouth Africa: 138 citing papers, 2.1% of this breakdown
0%40%Other 20.5%

Fields

  • Immunology and Microbiology67.1%
  • Medicine22.8%
  • Biochemistry, Genetics and Molecular Biology7.7%
  • Neuroscience0.6%
  • Agricultural and Biological Sciences0.3%
  • Engineering0.3%
  • Other1.2%

Topics

  • HIV Research and Treatment21.5%
  • Immune Cell Function and Interaction10.9%
  • HIV/AIDS drug development and treatment9%
  • HIV/AIDS Research and Interventions8.1%
  • T-cell and B-cell Immunology5.3%
  • Cytomegalovirus and herpesvirus research2.8%
  • Other42.4%

Coauthors

All papers

Open in search
  1. Distinct viral reservoirs in individuals with spontaneous control of HIV-1

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xu G. Yu - Nature 2020 cited by 418

  2. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1997 cited by 2,003

  3. Prolonged viral suppression with anti-HIV-1 antibody therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature 2022 cited by 207

  4. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

    Authors: , , , , , , , , , , , , , , - Nature 1997 cited by 2,067

  5. Phenotypic signatures of immune selection in HIV-1 reservoir cells

    Authors: , , , , , , , , , , , , - Nature 2023 cited by 190

  6. Combination anti-HIV antibodies provide sustained virological suppression

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2022 cited by 177

  7. Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barney S. Graham, Susan Moir, Richard A. Koup, John R. Mascola, James A. Hoxie, Anthony S. Fauci, Pablo Tebas, Tae‐Wook Chun - New England Journal of Medicine 2016 cited by 475

  8. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals

    Authors: , , , , , , , , , , , - The Journal of Experimental Medicine 2008 cited by 907

  9. Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Investigation 2019 cited by 323

  10. Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cell Host & Microbe 2023 cited by 120

  11. Early antibody therapy can induce long-lasting immunity to SHIV

    Authors: , , , , , , , , , , , , , , , , , , - Nature 2017 cited by 317

  12. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , María Lorenza Muiesan, Gabriele Tomasoni, Francesco Scolari, Alessandra Tucci, Camillo Rossi, Helen C. Su, Douglas B. Kuhns, Jeffrey I. Cohen, Luigi D. Notarangelo, John S. Tsang - Cell 2021 cited by 255

  13. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

    Authors: , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 856

  14. Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard A. Koup, Daniel C. Douek, Zonghui Hu, Edmund V. Capparelli, Barney S. Graham, John R. Mascola, Julie E. Ledgerwood, VRC 601 Study Team - Science Translational Medicine 2015 cited by 479

  15. A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Internal Medicine 2022 cited by 161

  16. The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bruce D. Walker, Jonathan Z. Li - The Journal of Infectious Diseases 2018 cited by 205

  17. Pathogenic Mechanisms of HIV Disease

    Authors: , , - Annual Review of Pathology Mechanisms of Disease 2011 cited by 445

  18. In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency

    Authors: , , , , , - Nature Medicine 1995 cited by 788

  19. Early establishment of a pool of latently infected, resting CD4 + T cells during primary HIV-1 infection

    Authors: , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1998 cited by 835

  20. Overexpression of T-bet in HIV infection is associated with accumulation of B cells outside germinal centers and poor affinity maturation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2019 cited by 105

  21. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2008 cited by 748

  22. Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant

    Authors: , , , , , , , , - New England Journal of Medicine 2013 cited by 582

  23. Persistence of HIV in Gut‐Associated Lymphoid Tissue despite Long‐Term Antiretroviral Therapy

    Authors: , , , , , , , , , , , , , - The Journal of Infectious Diseases 2008 cited by 564

  24. Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2022 cited by 87